Syndax CEO To Engage In The Novel Oncology Strategies At Citi Conference

Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company focused on advancing innovative cancer therapies, has announced that its Chief Executive Officer, Michael A. Metzger, will participate in a panel discussion at the Citi 2024 Global Healthcare Conference. The panel will explore novel mechanisms in oncology and is scheduled for Thursday, December 5, 2024, at 11:00 a.m. ET. The discussion will be available for live streaming through the Investor section of Syndax’s official website, where a replay of the event will also be accessible for a limited period.